Skip to main content

Table 1 Patients clinical features of LN + pancreatic tumors and distant metastasis

From: Comparable prevalence of distant metastasis and survival of different primary site for LN + pancreatic tumor

 

Total

No distance metastasis

Distance metastasis

P value

Age

   

 < 0.001

 18–49

521 (9.1)

464 (8.7)

57 (13.9)

 

 50–59

1412 (24.7)

1289 (24.2)

123 (30.1)

 

 60–69

2074 (36.2)

1948 (36.6)

126 (30.8)

 

   ≥ 70

1719 (30.0)

1616 (30.4)

103 (25.2)

 

Sex, no. (%)

   

0.730

 Male

2973 (51.9)

2764 (52.0)

209 (51.1)

 

 Female

2753 (48.1)

2553 (48.0)

200 (48.9)

 

Race, no. (%)

   

0.384

 White

4710 (82.3)

4377 (82.3)

333 (81.4)

 

 Black

592 (10.3)

553 (10.4)

39 (9.5)

 

 Other

424 (7.4)

387 (7.3)

37 (9.1)

 

Marital status, no. (%)

   

0.090

 Never married

709 (12.4)

657 (12.4)

52 (12.7)

 

 Married

3868 (67.6)

3576 (67.3)

292 (71.4)

 

 Divorced/widowed

1149 (20.1)

1084 (20.4)

65 (15.9)

 

Size, no. (%)

   

 < 0.001

  ≤ 2 cm

716 (12.5)

689 (13.0)

27 (6.6)

 

  ≤ 4 cm

3498 (61.1)

3294 (62.0)

204 (49.9)

 

  > 4 cm

1512 (26.4)

1334 (25.0)

178 (43.5)

 

Differentiation, no. (%)

   

 < 0.001

 Well

477 (8.3)

436 (8.2)

41 (10.0)

 

 Intermediate

2590 (45.2)

2464 (46.3)

126 (30.8)

 

 Poor/undifferentiated

2133 (37.3)

1994 (37.5)

139 (34.0)

 

 Missing

526 (9.2)

423 (8.0)

103 (25.2)

 

Lymph node ratio, no. (%)

   

 < 0.001

 1–25%

3466 (60.5)

3300 (62.1)

166 (40.5)

 

 26–50%

1505 (26.3)

1396 (26.3)

109 (26.7)

 

 > 50%

755 (13.2)

621 (11.7)

134 (32.8)

 

Number of malignant mass, no. (%)

   

0.047

 1

5493 (95.9)

5093 (95.8)

400 (97.8)

 

 > 1

233 (4.1)

224 (4.2)

9 (2.2)

 

Primary site no. (%)

   

 < 0.001

 Pancreas head

4877 (85.2)

4613 (86.8)

264 (64.5)

 

 Pancreas body tail

849 (14.8)

704 (13.2)

145 (35.5)

 

Stage, no. (%)

   

 < 0.001

 IIB

5003 (87.3)

5003 (94.1)

0

 

 III

314 (5.5)

314 (5.9)

0

 

 IV

409 (7.2)

0

409 (100%)